Literature DB >> 35118577

Umbilical Cord Mesenchymal Stem/Stromal Cells and Low-Dose Obeticholic Acid as a Possible Combined Treatment for Liver Fibrosis.

Ahmed Lotfy1, Shimaa El-Metwaly2, Reham Soliman2,3, Ayman A Hassan2, Gamal Shiha4,5.   

Abstract

Entities:  

Keywords:  Liver Fibrosis; Mesenchymal Stem/Stromal Cells; Obeticholic acid

Mesh：

Substances：

Year:  2022        PMID： 35118577     DOI： 10.1007/s12015-022-10346-8

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN： 2629-3277            Impact factor:   6.692


× No keyword cloud information.
  2 in total

1.  Comparative study of biological characteristics of mesenchymal stem cells isolated from mouse bone marrow and peripheral blood.

Authors:  Ahmed Lotfy; Yasser M El-Sherbiny; Richard Cuthbert; Elena Jones; Ahmed Badawy
Journal:  Biomed Rep       Date:  2019-09-02

2.  Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro.

Authors:  Li-Ting Zhang; Xue-Bin Peng; Xue-Qin Fang; Jun-Feng Li; Hong Chen; Xiao-Rong Mao
Journal:  Int J Mol Med       Date:  2018-02-16       Impact factor: 4.101
  2 in total
  1 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.